Clinical Trial Update: Betaine and Peroxisome Biogenesis Disorders [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluated betaine for peroxisome biogenesis disorders; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peroxisome Biogenesis Disorders

Drugs mentioned

• Betaine (betaine (trimethylglycine))

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Peroxisome Biogenesis Disorders | Phase 3 | Status: COMPLETED | Results posted: 2016-06-28